Literature DB >> 10938125

Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

B Mannhardt1, S A Weinzimer, M Wagner, M Fiedler, P Cohen, P Jansen-Dürr, W Zwerschke.   

Abstract

The E7 protein encoded by human papillomavirus type 16 is one of the few viral genes that can immortalize primary human cells and thereby override cellular senescence. While it is generally assumed that this property of E7 depends on its interaction with regulators of the cell cycle, we show here that E7 targets insulin-like growth factor binding protein 3 (IGFBP-3), the product of a p53-inducible gene that is overexpressed in senescent cells. IGFBP-3 can suppress cell proliferation and induce apoptosis; we show here that IGFBP-3-mediated apoptosis is inhibited by E7, which binds to IGFBP-3 and triggers its proteolytic cleavage. Two transformation-deficient mutants of E7 failed to inactivate IGFBP-3, suggesting that inactivation of IGFBP-3 may contribute to cell transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938125      PMCID: PMC86123          DOI: 10.1128/MCB.20.17.6483-6495.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  93 in total

1.  Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.

Authors:  H Nguyen; D M Gitig; A Koff
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFbeta1.

Authors:  S R Edmondson; M M Murashita; V C Russo; C J Wraight; G A Werther
Journal:  J Cell Physiol       Date:  1999-05       Impact factor: 6.384

3.  Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.

Authors:  F Rozen; J Zhang; M Pollak
Journal:  Int J Oncol       Date:  1998-10       Impact factor: 5.650

Review 4.  The INK4A/ARF locus and its two gene products.

Authors:  N E Sharpless; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

5.  Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.

Authors:  W Zwerschke; S Mazurek; P Massimi; L Banks; E Eigenbrodt; P Jansen-Dürr
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization.

Authors:  C M Counter; W C Hahn; W Wei; S D Caddle; R L Beijersbergen; P M Lansdorp; J M Sedivy; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes.

Authors:  C J Wraight; I J Liepe; P J White; A R Hibbs; G A Werther
Journal:  J Invest Dermatol       Date:  1998-08       Impact factor: 8.551

8.  Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin-1alpha.

Authors:  M Iglesias; K Yen; D Gaiotti; A Hildesheim; M H Stoler; C D Woodworth
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

9.  The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.

Authors:  H Stöppler; M C Stöppler; E Johnson; C M Simbulan-Rosenthal; M E Smulson; S Iyer; D S Rosenthal; R Schlegel
Journal:  Oncogene       Date:  1998-09-10       Impact factor: 9.867

10.  Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells.

Authors:  L J Schedlich; T F Young; S M Firth; R C Baxter
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  22 in total

Review 1.  Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.

Authors:  Oishee Chakrabarti; Sudhir Krishna
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

Review 2.  Cancer.

Authors:  Adda Grimberg
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

3.  Activation of various downstream signaling molecules by IGFBP-3.

Authors:  Hanief Mohammad Shahjee; Nisan Bhattacharyya
Journal:  J Cancer Ther       Date:  2014-08-01

4.  Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3.

Authors:  Munenori Takaoka; Hideki Harada; Claudia D Andl; Kenji Oyama; Yoshio Naomoto; Kelly L Dempsey; Andres J Klein-Szanto; Wafik S El-Deiry; Adda Grimberg; Hiroshi Nakagawa
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

5.  Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins.

Authors:  Allison J Berger; Astrid Baege; Tracy Guillemette; James Deeds; Ron Meyer; Gary Disbrow; Richard Schlegel; Robert Schlegel
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.

Authors:  Yunying Zhou; Qishu Zhang; Ge Gao; Xiaoli Zhang; Yafei Liu; Shoudao Yuan; Xiaowei Wang; Jason J Chen
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 7.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 8.  Oncogenic activities of human papillomaviruses.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

Review 9.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

10.  Biomarkers in cervical cancer.

Authors:  Eun-Kyoung Yim; Jong-Sup Park
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.